About this trial
The overarching goal of our research is to develop personalized and accessible healthy aging lifestyle interventions aimed at promoting physical activity (PA) and improving health among community-dwelling older adults living alone with cognitive decline (LACD). To achieve this goal, the purpose of this project is to determine whether wearable and app-based mHealth intervention component(s) will contribute to increased PA and improved health outcomes in older adults LACD. Our specific aims are to: identify and evaluate mHealth intervention components that practically and significantly contribute to enhanced mechanistic outcomes (e.g., self-efficacy, outcome expectations) and increased PA (primary outcome) in older adults LACD over a 6-month period; determine the optimal combinations of intervention components for future efficacy testing; elucidate the mechanism of behavioral change (MoBC) and potential outcomes of these intervention components, namely, the mediating effects of MoBC variables (e.g., self-efficacy, outcome expectations) on the relationship between intervention components and change in PA. The first two aims are primary and fully-powered. The third aim is exploratory. The aims will support a refined, data-driven intervention design for a subsequent larger trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participant must be at least 65 years of age older
Participant must be living alone in the U.S. for the next 6 months
Participant must have report mild cognitive decline [We will use a short self-report AD8 measure of cognitive concerns. Those scoring positive on the AD8 (≥2) will qualify as mild cognitive decline];
Participant must own an Android/Apple smartphone
Disqualifiers
Foreign residents or visitors
Trial design
Factorial
Treatments tested in this trial
Fitness app for self-efficacy
Other interventionAI-driven personalized exercise prescription via a fitness app. This targets self-efficacy.
Social network via app for social support
Other interventionParticipants will be provided access to a social network via app. This targets social support.
Health education app targeting outcome expectations
Other interventionParticipants are provided with an app-based health education. This targets outcome expectations.
Treatment groups
8
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Fitbit MVPA
Fitbit Inspire 3 Tracker will be used to assess participants' MVPA (active time which includes both fairly active time and very active time). Fairly active; duration associated with light intensity activities, i.e., walking, light cycling, housework (\~3-6 METs). Very active; duration associated with high intensity activities, i.e., running, aerobic workouts (\>6 METs).
Physical Activity
We will use the Physical Activity Scale for the Elderly to assess PA. Higher scores means more physical activity. (Low activity: \<100; Moderate: 100-250; High: \>250)
Mechanism of behavior change (MoBC) variables
Psychometrically validated questionnaires will be used to assess beliefs: self-efficacy, social support, and outcome expectations. Self-efficacy; low score indicates low confidence in ability to perform behavior, high score indicates strong confidence. Social support; low score indicates poor support from family or friends, high score indicates great support. Outcome expectation; low score indicates the belief that behavior won't help, high score indicates the belief that the behavior will lead to positive outcome.
Secondary outcomes
Quality of life (QoL)
We will select the brief Older People's Quality of Life questionnaire to assess quality of life (OPQOL-BRIEF). Minimum: 13 (very poor quality of life) Maximum: 65 (excellent quality of life)
Psychosocial wellbeing
We will assess wellbeing using the World Health Organization Well-Being Index (WHO-5) questionnaire. 0 -12 - Low well-being; possible depression (screen positive) 13 - 19 - Moderate well-being 20 - 25 - High well-being
Cognition
To assess older adults' cognition (thinking and memory), we will use the 5-minute Montreal Cognitive Assessment (MoCA). 26 - 30: Normal; Indicates health cognitive functioning for most adults. 18 - 25: Mild Cognitive Impairment (MCI); Shows noticeable memory or thinking issues that do not severely disrupts daily life. 10 - 17: Moderate Cognitive Impairment; Suggests a heightened progression towards early-to-mid stage dementia. Less than 10: Severe Cognitive Impairment.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
The University of Tennessee, Knoxville
Lead sponsor
Arizona State University
Collaborator
Oregon Research Institute
Collaborator
National Institute on Aging (NIA)
Collaborator